Steroid Treatment and Aseptic Necrosis of the Femoral Head in Renal Transplant Recipients
Overview
Affiliations
The subject of our study was 546 renal transplant recipients with a graft survival for minimum 12 months. Of these, 29 renal recipients (5.3%) developed aseptic necrosis of the femoral head. The examination revealed that there were no significant differences between the renal recipients with hip necrosis and the control group in the total quantities of administered glucocorticosteroids, whereas there was a highly significant correlation between the two groups in the number of the intravenously administered methylprednisolone pulse doses.
Mont M, Pivec R, Banerjee S, Issa K, Elmallah R, Jones L J Arthroplasty. 2015; 30(9):1506-1512.e5.
PMID: 25900167 PMC: 7127809. DOI: 10.1016/j.arth.2015.03.036.
Kawedia J, Kaste S, Pei D, Panetta J, Cai X, Cheng C Blood. 2010; 117(8):2340-7.
PMID: 21148812 PMC: 3062406. DOI: 10.1182/blood-2010-10-311969.
Steroid induced osteonecrosis: An analysis of steroid dosing risk.
Powell C, Chang C, Naguwa S, Cheema G, Gershwin M Autoimmun Rev. 2010; 9(11):721-43.
PMID: 20621176 PMC: 7105235. DOI: 10.1016/j.autrev.2010.06.007.
Corticosteroid-induced adverse events in adults: frequency, screening and prevention.
Fardet L, Kassar A, Cabane J, Flahault A Drug Saf. 2007; 30(10):861-81.
PMID: 17867724 DOI: 10.2165/00002018-200730100-00005.
McKee M, Waddell J, Kudo P, Schemitsch E, Richards R CMAJ. 2001; 164(2):205-6.
PMID: 11332313 PMC: 80680.